CRISIL.NS(CRISIL.NS)
CRISIL.NS
No analyst ratings available
No analyst price targets available for CRISIL.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $43.02B | $48.42B | $54.19B |
| Low | $42.95B | $48.29B | $53.87B |
| High | $43.08B | $48.55B | $54.51B |
| EBITDA Avg | $13.26B | $14.93B | $16.71B |
| Low | $13.24B | $14.89B | $16.61B |
| High | $13.28B | $14.97B | $16.80B |
| EBIT Avg | $11.77B | $13.25B | $14.83B |
| Low | $11.76B | $13.21B | $14.74B |
| High | $11.79B | $13.29B | $14.92B |
| Net Income Avg | $8.60B | $10.55B | $11.81B |
| Low | $8.15B | $10.01B | $11.78B |
| High | $9.04B | $10.89B | $11.84B |
| EPS Avg | $117.57 | $142.87 | $161.50 |
| Low | $111.47 | $136.84 | $161.06 |
| High | $123.66 | $148.89 | $161.94 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 1 | 1 / 1 |